MissionIR Articles
-
Jean H. Sewell Joins Shore Bank (HMPR) as Senior Vice President – Director of Marketing
Yesterday, the Bank of Hamption Roads’ (“BHR”) holding company, Hampton Roads Bankshares, Inc. (Nasdaq: HMPR), announced that Jean H. Sewell has joined its Shore Bank entity as Senior Vice President – Director of Marketing. Ms.…
-
Aethlon Medical Inc. (AEMD) Starts Presentation at the Biotech Showcase 2013 Conference
Aethlon Medical is a development stage medical device company focused on creating devices for the treatment of cancer, infectious diseases and other life-threatening conditions. The company’s Aethlon Hemopurifier is intended for the treatment of cancer,…
-
Medbox Inc. (MDBX) Starts Presentation at the Biotech Showcase 2013 Conference
Medbox, through its subsidiary Prescription Vending Machines Inc., engages in developing a patented machine that dispenses medication to individuals based on biometric identification. The company’s flagship product is MedBox, an automated medicine dispensing machine that…
-
Amorcyte, a NeoStem company (NBS) Starts Presentation at the Biotech Showcase 2013 Conference
Amorcyte is a biopharm company engaged in the development of proprietary cellular therapies in cardiovascular disease, immunology and regenerative medicine primarily in the United States. Its lead product candidate, AMR-001, which is for the prevention…
-
Atossa Genetics, Inc. (ATOS) Starts Presentation at the OneMedForum 2013 Conference
Atossa Genetics, known as The Breast Health Company, is engaged in the prevention of breast cancer through commercializing patented, FDA-approved diagnostic medical devices and patented, laboratory-developed tests for detecting precursors to breast cancer up to…
-
Athersys Inc. (ATHX) Starts Presentation at the Biotech Showcase 2013 Conference
Athersys is a clinical stage biopharm company growing a pipeline of highly differentiated therapeutics to treat significant and life-threatening diseases. The company’s current product development portfolio consists of MultiStem®, a proprietary stem cell product for…
-
OncoSec Medical Inc. (ONCS) Starts Presentation at the Biotech Showcase 2013 Conference
OncoSec Medical is a biotech company focused on the development of treatments addressing advanced-stage skin cancer, specifically: melanoma, Merkel cell lymphoma and cutaneous T-cell lymphoma. ONCS’ proprietary technology, OncoSec Medical System™ (OMS), is based on…
-
Neuralstem Inc. (CUR) Starts Presentation at the Biotech Showcase 2013 Conference
Neuralstem, a development-stage company focused on the development and commercialization of treatments for central nervous system disease, has developed and maintains a portfolio of patents and patent applications that form base for its research and…
-
Targeted Medical Pharma, Inc. (TRGM) Starts Presentation at the OneMedForum 2013 Conference
Targeted Medical Pharma is a specialty pharmaceutical company engaged in developing and distributing prescription medical foods to physicians and pharmacies in the U.S. and the Middle East. The company manufactures 10 proprietary prescription-only medical foods…
-
ProMetic Life Sciences (PFSCF) Starts Presentation at the Biotech Showcase 2013 Conference
ProMetic Life Sciences operates through a group of subsidiaries to specialize in the design of small molecules that mimic unique and specific interactions between proteins. The company’s technologies are applicable to large-scale drug purification, drug…
-
IntelGenx Technology Corp. (IGX) Starts Presentation at the OneMedForum 2013 Conference
IntelGenx Technology is a drug delivery company engaged in developing oral controlled-release products and novel rapidly disintegrating delivery systems. Using its unique multiple layer delivery system, the company provides zero-order release of active drugs in…
-
NovaBay Pharmaceuticals Inc. (NBY) Starts Presentation at the Biotech Showcase 2013 Conference
NovaBay Pharmaceuticals is a clinical-stage biotech company focused on the development of its proprietary and patented Aganocide® compounds. NBY focuses its technology on four therapeutic areas: dermatology, ophthalmology, urology and hospital infections. The company has…
-
BioLife Solutions, Inc. (BLFS) Starts Presentation at the OneMedForum 2013 Conference
BioLife Solutions is a leading developer, manufacturer and marketer of patented hypothermic storage and cryopreservation solutions for cells and tissues. The company markets its proprietary HypoThermosol and CryoStor solutions to academic and commercial organizations involved…
-
Shire (SHPG) Starts Presentation at the Biotech Showcase 2013 Conference
Shire is a biopharmaceutical company that focuses its business on attention deficit hyperactivity disorder, human genetic therapies, gastrointestinal diseases and regenerative medicine as well as opportunities in other therapeutic areas. SHPG’s in-licensing, merger and acquisition…
-
Organovo Holdings Inc. (ONVO) Starts Presentation at the Biotech Showcase 2013 Conference
Organovo Holdings focuses on breakthrough 3D biology capabilities to create tissue on-demand for research and surgical applications. The company’s NovoGen MMX Bioprinter™ is the world’s only commercial bioprinter with the proven ability to create tissue.…
-
Resverlogix Corp. (RVXCF) Starts Presentation at the Biotech Showcase 2013 Conference
Resverlogix is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. The company is developing RVX-208 for the treatment of atherosclerosis. RVX’s business model is to seek strategic opportunities through…
-
Amarantus Bioscience, Inc. (AMBS) Starts Presentation at the OneMedForum 2013 Conference
Amarantus Bioscience is a development-stage biotechnology company focused on developing certain biologics surrounding its intellectual property and proprietary technologies for treating and/or diagnosing Parkinson’s disease, traumatic brain injury and other human diseases. Amarantus owns the…
-
Oragenics, Inc. (OGEN) Starts Presentation at the OneMedForum 2013 Conference
Oragenics is dedicated to becoming a global leader in probiotics for oral health in humans and pets and in novel antibiotics against infectious disease. The company is engaged in developing, marketing and selling proprietary probiotics…
-
ZBB Energy Corp. (ZBB) Secures Order for Grid Independent ZBB EnerSystem with University of Technology Sydney
ZBB Energy, the developer of cutting-edge electrical power management platform architectures that fit the growing global need for distributed renewable energy, energy efficiency, power quality, and ultimately grid modernization, reported today that the company has…
-
NeuroMetrix, Inc. (NURO) Starts Presentation at the OneMedForum 2013 Conference
NeuroMetrix is an innovative medical device company focused on developing and marketing home use and point-of-care devices, associated consumables and support software for treating and managing diabetes and its complications. Nerve-related complications of diabetes, or…
Search Articles
Latest Articles
- MissionIRNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Aims to Close Critical Gap in Early Cardiac Detection
- MissionIRNewsBreaks – D-Wave Quantum Inc. (NYSE: QBTS) and Department of Commerce Sign Letter of Intent for $100 Million in CHIPS and Science Act Funding to Accelerate U.S. Leadership in Quantum Computing
- The Untapped Potential of Greenland’s Jameson Land Basin Creates Major Opportunity for Greenland Energy Company (NASDAQ: GLND)
- Regentis Biomaterials Ltd. (NYSE American: RGNT) and the Off-the-Shelf Opportunity in Knee Cartilage Repair
- MissionIRNewsBreaks – ParaZero Technologies Ltd. (NASDAQ: PRZO) Conducts First U.S. Live DefendAir Counter-Drone Demonstration